Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
Journal of Hematology & Oncology
|
November 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
Nicola Tumino, Gerrit Weber, Francesca Besi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 26, 2024
Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
Rebecca Nicolai, Pietro Merli, Patricia Moran Alvarez, et al.
Blood
|
February 1, 2011
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells
Concetta Quintarelli, Gianpietro Dotti, Sayyeda T Hasan, et al.
Journal for Immunotherapy of Cancer
|
March 19, 2021
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
Matteo Caforio, Cristina Sorino, Ignazio Caruana, et al.
Oncoimmunology
|
June 7, 2018
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma
Concetta Quintarelli, Domenico Orlando, Iolanda Boffa, et al.
Cells
|
November 27, 2021
B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies
Federica Pulvirenti, Ane Fernandez Salinas, Cinzia Milito, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 5, 2026
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model
Mattia Fumagalli, Dongjie An, Luca Simula, et al.
Blood
|
March 3, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
Marco Becilli, Pietro Merli, Mattia Algeri, et al.
Blood Advances
|
August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Frontiers in Cell and Developmental Biology
|
February 9, 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation
Clara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
Journal of Hematology & Oncology
|
November 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
Nicola Tumino, Gerrit Weber, Francesca Besi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 26, 2024
Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
Rebecca Nicolai, Pietro Merli, Patricia Moran Alvarez, et al.
Blood
|
February 1, 2011
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells
Concetta Quintarelli, Gianpietro Dotti, Sayyeda T Hasan, et al.
Journal for Immunotherapy of Cancer
|
March 19, 2021
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
Matteo Caforio, Cristina Sorino, Ignazio Caruana, et al.
Oncoimmunology
|
June 7, 2018
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma
Concetta Quintarelli, Domenico Orlando, Iolanda Boffa, et al.
Cells
|
November 27, 2021
B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies
Federica Pulvirenti, Ane Fernandez Salinas, Cinzia Milito, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 5, 2026
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model
Mattia Fumagalli, Dongjie An, Luca Simula, et al.
Blood
|
March 3, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
Marco Becilli, Pietro Merli, Mattia Algeri, et al.
Blood Advances
|
August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Frontiers in Cell and Developmental Biology
|
February 9, 2023
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation
Clara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Page
of 9